Cargando…
Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
Huntington’s disease (HD) is a devastating, progressive, and fatal neurodegenerative disorder inherited in an autosomal dominant manner. This condition is characterized by motor dysfunction (chorea in the early stage, followed by bradykinesia, dystonia, and motor incoordination in the late stage), p...
Autores principales: | Wiprich, Melissa Talita, Bonan, Carla Denise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281137/ https://www.ncbi.nlm.nih.gov/pubmed/34276284 http://dx.doi.org/10.3389/fnins.2021.657338 |
Ejemplares similares
-
Purinergic Signaling in Liver Pathophysiology
por: Jain, Shanu, et al.
Publicado: (2021) -
Purinergic Signalling in Physiology and Pathophysiology
por: Sluyter, Ronald
Publicado: (2023) -
Editorial: Purinergic Signaling in Health and Disease
por: Boué-Grabot, Eric, et al.
Publicado: (2020) -
Purinergic Signaling in the Vertebrate Olfactory System
por: Rotermund, Natalie, et al.
Publicado: (2019) -
The Pathophysiology and Pharmacological Treatment of Huntington Disease
por: Pidgeon, Connie, et al.
Publicado: (2013)